After the Oklahoma case ruling, Johnson & Johnson stocks rallied, but the ruling is a warning to industry leaders that change is necessary.
William Soliman, PhD, MPhil, MA
Advertisement
Articles by William Soliman, PhD, MPhil, MA
Advertisement
Latest Updated Articles
Opinion: The Opioid Crisis: Where Does Pharma Go From Here?Published: September 10th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Multifaceted Approach to Navigating Career Transitions in Pharmacy
2
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
3
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
4
Oxaliplatin as Part of Sequential Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
5
